Document:

EXHIBIT 10.2

                              REVOLVING CREDIT NOTE
                              ---------------------

No. 1                                                          November 12, 2002
$30,000,000.00

     FOR VALUE RECEIVED, the undersigned, AMERIVEST PROPERTIES INC., a Maryland
corporation (the "Borrower"), promises to pay, without offset or counterclaim,
to the order Fleet National Bank (hereinafter, together with its successors in
title and assigns, called the "Lender") at the head office of Fleet National
Bank, as Agent (the "Agent") at 100 Federal Street, Boston, Massachusetts 02110,
the principal sum of Thirty Million Dollars ($30,000,000.00) or, if less, the
aggregate unpaid principal amount of all Loans made by the Lender to the
Borrower pursuant to the Revolving Credit Agreement dated as of November 12,
2002 among the Lender, the Borrower, the other lending institutions named
therein and the Agent, as amended from time to time (the "Credit Agreement").
Capitalized terms used herein and not otherwise defined herein shall have the
meanings assigned to them in the Credit Agreement. Unless otherwise provided
herein, the rules of interpretation set forth in ss.1.2 of the Credit Agreement
shall be applicable to this Note.

     The Borrower also promises to pay (a) principal from time to time at the
times provided in the Credit Agreement and (b) interest from the date hereof on
the principal amount from time to time unpaid at the rates and times set forth
in the Credit Agreement and in all cases in accordance with the terms of the
Credit Agreement. Late charges and other charges and default rate interest shall
be paid by Borrower in accordance with the terms of the Credit Agreement. The
entire outstanding principal amount of this Note, together with all accrued but
unpaid interest thereon, shall be due and payable in full on the Maturity Date.
The Lender may endorse the record relating to this Note with appropriate
notations evidencing advances and payments of principal hereunder as
contemplated by the Credit Agreement.

     This Note is issued pursuant to, is entitled to the benefits of, and is
subject to the provisions of the Credit Agreement. The principal of this Note is
subject to prepayment in whole or in part in the manner and to the extent
specified in the Credit Agreement. The principal of this Note, the interest
accrued on this Note and all other Obligations of the Borrower are full recourse
obligations of the Borrower, and all of its Real Estate Assets, and its other
properties shall be available for the payment and performance of this Note, the
interest accrued on this Note, and all of such other Obligations. In case an
Event of Default shall occur and be continuing, the entire unpaid principal
amount of this Note and all of the unpaid interest accrued thereon may become or
be declared due and payable in the manner and with the effect provided in the
Credit Agreement.

     The Borrower and all endorsers hereby waive presentment, demand, protest
and notice of any kind in connection with the delivery, acceptance, performance
and enforcement of this Note, and also hereby assent to extensions of time of
payment or forbearance or other indulgences without notice.

     This Note and the obligations of the Borrower hereunder shall be governed
by and interpreted and determined in accordance with the laws of the
Commonwealth of Massachusetts (excluding the laws applicable to conflicts or
choice of law). The Borrower has waived its right to a jury trial with respect
to any action or claim arising out of this Note pursuant to ss.24 of the Credit
Agreement.

     IN WITNESS WHEREOF, the Borrower has caused this Note to be duly executed
in its name as an instrument under seal on the date first above written.

WITNESS:                                    AMERIVEST PROPERTIES INC.

/s/  Jean M. Gonzales                        By:  /s/  John B. Greenman
------------------------                        -------------------------------
     Jean M. Gonzales                                  John B. Greenman
                                             Its       Vice PresidentEXHIBIT 10.64
                                 PAILLA M. REDDY
                                  7 OSER AVENUE
                            HAUPPAUGE, NY 11788-3808

Advanced Nutraceuticals, Inc.
106 S. University Boulevard, #14
Denver, CO  80209

Attention: Gregory Pusey, President

Dear Greg:

This letter shall  constitute a Conversion  Notice  pursuant to Section 3 of the
Additional Terms and Conditions of the Subordinated  Convertible Promissory Note
dated  November  17,  2001 (the  "Note").  I elect to convert  $1,124,849.32  of
principal and interest owed to me pursuant to the Note into 2,045,181  shares of
the  common  stock  (the  "Securities")of  Advanced  Nutraceuticals,  Inc.  (the
"Company").  I understand that, as a result of this conversion,  ANI will owe me
pursuant to the Note $500,000, plus interest, which will accrue after August 26,
2002. I confirm to you the following representations:

1.   The  Securities to be issued will be evidenced by a certificate  which will
     have imprinted on its face a "restricted" legend noting that the securities
     have not been  registered  under  the U.S.  securities  laws and may not be
     resold except  pursuant to an effective  registration  statement  under the
     U.S.  Securities  Act of 1933  (the  "Securities  Act") or  pursuant  to an
     exemption from registration, the availability of which is to be established
     to the Company's satisfaction. I will not sell or otherwise transfer any of
     the Securities unless registered or pursuant to an exemption;

2.   The Company will lodge "stop transfer" instructions in its transfer records
     concerning the "restricted" nature of the securities to be issued;

3.   I have no knowledge of any legal restrictions  applicable to me which would
     preclude the issuance of the shares to me;

4.   I am acquiring the  Securities for my own account and will not be acquiring
     the shares pursuant to a plan to resell or otherwise distribute the shares;

5.   I have the legal right and power to acquire the  Securities and to make the
     representations to the Company in this letter.

6.   I have had the opportunity to review information  regarding the Company and
     have had the  opportunity  to ask  questions  of and receive  answers  from
     representatives  of the  Company and to obtain any  additional  information
     desired by me.

                                                     Sincerely yours,

Dated as of August 26, 2002                          /s/ Pailla M. Reddy
                                                     ---------------------------
                                                     Pailla M. Reddy
Enclosures

cc:  Robert M. BearmanEXHIBIT 10.65
                            CAMBRIDGE HOLDINGS, LTD.
                        106 S. UNIVERSITY BOULEVARD, #14
                                DENVER, CO 80209

Advanced Nutraceuticals, Inc.
106 S. University Boulevard, #14
Denver, CO  80209

Attention: Gregory Pusey, President

This letter shall  constitute a Conversion  Notice  pursuant to Section 3 of the
Additional Terms and Conditions of our Subordinated  Convertible Promissory Note
dated January 2, 2002 (the "Note")  pursuant to which Cambridge  Holdings,  Ltd.
elects to convert the  $261,315.07 of principal and interest owed to it pursuant
to the Note  into  475,118  shares  of the  common  stock  (the  "Securities")of
Advanced Nutraceuticals, Inc. (the "Company"). On behalf of Cambridge, I confirm
to you the following representations:

1.   The  Securities to be issued will be evidenced by a certificate  which will
     have imprinted on its face a "restricted" legend noting that the securities
     have not been  registered  under  the U.S.  securities  laws and may not be
     resold except  pursuant to an effective  registration  statement  under the
     U.S.  Securities  Act of 1933  (the  "Securities  Act") or  pursuant  to an
     exemption from registration, the availability of which is to be established
     to the  Company's  satisfaction.  Cambridge  will  not  sell  or  otherwise
     transfer  any  of  the  Securities  unless  registered  or  pursuant  to an
     exemption;

2.   The Company will lodge "stop transfer" instructions in its transfer records
     concerning the "restricted" nature of the securities to be issued;

3.   Cambridge has no knowledge of any legal restrictions applicable to it which
     would preclude the issuance of the shares to Cambridge;

4.   Cambridge is acquiring the  Securities  for its own account and will not be
     acquiring the shares  pursuant to a plan to resell or otherwise  distribute
     the shares;

5.   Cambridge  has the legal right and power to acquire the  Securities  and to
     make the representations to the Company in this letter.

6.   Cambridge  has had the  opportunity  to review  information  regarding  the
     Company and has had the opportunity to ask questions of and receive answers
     from   representatives   of  the  Company  and  to  obtain  any  additional
     information desired by it.

                                                  Sincerely yours,

Dated as of August 26, 2002                       By:   /s/ Jeffrey G. McGonegal
                                                        ------------------------
                                                        Jeffrey G. McGonegal
                                                        Chief Financial Officer
Enclosures

cc:  Robert M. BearmanEXHIBIT 10.66
                        GLENWOOD CAPITAL PARTNERS I, L.P.
                                  9150 Glenwood
                           Overland Park, Kansas 66212

Advanced Nutraceuticals, Inc.
106 S. University Boulevard, #14
Denver, CO  80209

Attention: Gregory Pusey, President

Dear Greg:

This letter shall  constitute a Conversion  Notice  pursuant to Section 3 of the
Additional Terms and Conditions of the Subordinated  Convertible Promissory Note
dated July 19, 2002 (the "Note")  pursuant to which Glenwood  Capital Partner I,
L.P.  ("Glenwood")  elects to convert $176,275.34 of principal and interest owed
to it  pursuant  to the Note  into  320,501  shares  of the  common  stock  (the
"Securities")of  Advanced  Nutraceuticals,  Inc. (the  "Company").  On behalf of
Glenwood, I confirm to you the following representations:

1.   The  Securities to be issued will be evidenced by a certificate  which will
     have imprinted on its face a "restricted" legend noting that the securities
     have not been  registered  under  the U.S.  securities  laws and may not be
     resold except  pursuant to an effective  registration  statement  under the
     U.S.  Securities  Act of 1933  (the  "Securities  Act") or  pursuant  to an
     exemption from registration, the availability of which is to be established
     to the Company's satisfaction. Glenwood will not sell or otherwise transfer
     any of the Securities unless registered or pursuant to an exemption;

2.   The Company will lodge "stop transfer" instructions in its transfer records
     concerning the "restricted" nature of the securities to be issued;

3.   Glenwood has no knowledge of any legal restrictions  applicable to Glenwood
     which would preclude the issuance of the shares to Glenwood;

4.   Glenwood is acquiring  the  Securities  for its own account and will not be
     acquiring the shares  pursuant to a plan to resell or otherwise  distribute
     the shares;

5.   Glenwood  has the legal  right and power to acquire the  Securities  and to
     make the representations to the Company in this letter.

6.   Glenwood  has had the  opportunity  to  review  information  regarding  the
     Company and has had the opportunity to ask questions of and receive answers
     from   representatives   of  the  Company  and  to  obtain  any  additional
     information desired by it.

                                                Sincerely yours,

Dated as of August 26, 2002                     By:  /s/ Randall D. Humphreys
                                                     --------------------------
                                                     Randall D. Humphreys
                                                     Authorized Representative
Enclosures

cc:      Robert M. Bearman

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}]]